Labassure is the diagnostics arm of the Advanced Genomics Institute and Laboratory Medicine (AGILE), committed to delivering accurate, science-backed, and patient-centric diagnostic services. As a genomics-driven facility, Labassure stands at the forefront of precision medicine, offering a wide portfolio of specialized tests across medical domains such as pediatrics, obstetrics, gynecology, fetal medicine, infertility, oncology, ophthalmology, infectious diseases, and more.


With deep expertise in both conventional and advanced genetic technologies, Labassure supports clinicians with high-quality, evidence-based diagnostics that enable better decisions for diagnosis, treatment, and patient care. Our reports are designed to be clinician-friendly, actionable, and rooted in the latest scientific advancements.

What Sets Labassure Apart?

01
Multidisciplinary Expertise

From cytogenetics to molecular diagnostics and next-generation sequencing (NGS), we provide end-to-end solutions across specialties.

02
Clinician-Centric Design

All test workflows and reports are structured to aid practical, real-time clinical decision-making.

03
Integrated Training & Research

Labassure functions not just as a lab, but as a learning ecosystem—offering internships, hands-on training, and collaborative research opportunities.

04
Patient-Focused Values

We understand the emotional, financial, and clinical weight of diagnostics. That’s why we strive for accuracy, empathy, and clarity in everything we do.

Quality & Accreditation
  • Labassure is accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL) in accordance with the ISO15189:2022 standard (Certificate No:MC-6232), underscoring our adherence to globally recognized medical testing standards.
  • We are also registered with national authorities for the provision of genetic diagnostic services (Certificate No.: 13071001), reflecting our commitment to safe, ethical, and reliable genetic testing.
  • In recognition of our infrastructure and capabilities, Labassure was approved by the Indian Council of Medical Research (ICMR) for COVID-19 RT-PCR testing (Reg. No.: AGILMPLCD) during the pandemic—an acknowledgment of our contribution to national diagnostic preparedness and public health.
  • At Labassure, science and service converge to enable precision diagnostics that make a real difference—for clinicians, for patients, and for the future of healthcare.
MC-6232